Disease-modifying antirheumatic drugs – Old and new: A brief overview
Rheumatological disorders comprise a vast subset of conditions with differing manifestations but overlap in pathogenesis. Disease-modifying antirheumatic drugs (DMARDs) are a diverse group of medications which aim at the various pathogenic factors leading to these disorders. DMARDs are of three broa...
Main Authors: | Vidya Divakar Baliga, Raghuveer S Prabhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Clinical Dermatology Review |
Subjects: | |
Online Access: | http://www.cdriadvlkn.org/article.asp?issn=2542-551X;year=2019;volume=3;issue=1;spage=47;epage=56;aulast=Baliga |
Similar Items
-
Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting
by: Rieke Alten, et al.
Published: (2018-01-01) -
Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
by: Abhishek Zanwar, et al.
Published: (2017-01-01) -
Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis
by: Vikramraj K Jain, et al.
Published: (2017-01-01) -
Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy
by: Anna Czekalska, et al.
Published: (2019-08-01) -
Short time administration of antirheumatic drugs - Methotrexate as a strong inhibitor of osteoblast's proliferation in vitro
by: Annussek Tobias, et al.
Published: (2012-09-01)